$SRDX
SURMODICS INC

2018 Q3 Form 10-K Financial Statement

#000156459019045173 Filed on December 03, 2019

View on sec.gov

Income Statement

Concept 2018 Q3 2018 Q2 2018 Q1
Revenue $23.04M $22.23M $19.06M
YoY Change 14.86% 24.94% 8.88%
Cost Of Revenue $4.090M $4.104M $2.910M
YoY Change 23.19% 40.84% 13.67%
Gross Profit $18.95M $18.12M $16.15M
YoY Change 13.2% 21.83% 8.1%
Gross Profit Margin 82.26% 81.54% 84.74%
Selling, General & Admin $6.510M $5.980M $6.440M
YoY Change 22.6% 14.3% 26.77%
% of Gross Profit 34.35% 33.0% 39.88%
Research & Development $12.59M $9.778M $10.77M
YoY Change 29.66% 23.35% 31.18%
% of Gross Profit 66.44% 53.95% 66.69%
Depreciation & Amortization $1.720M $1.605M $1.586M
YoY Change 10.97% 14.23% 19.43%
% of Gross Profit 9.08% 8.86% 9.82%
Operating Expenses $21.39M $9.778M $6.440M
YoY Change 31.07% -25.69% -51.47%
Operating Profit -$2.441M -$6.250M $525.0K
YoY Change -688.19% -458.58% -68.69%
Interest Expense $410.0K $960.0K -$210.0K
YoY Change -286.36% -295.92% 75.0%
% of Operating Profit -40.0%
Other Income/Expense, Net $0.00 $955.0K -$211.0K
YoY Change -294.9%
Pretax Income -$2.030M -$5.295M $314.0K
YoY Change -1168.42% -522.59% -79.87%
Income Tax -$680.0K -$2.613M -$1.220M
% Of Pretax Income -388.54%
Net Earnings -$1.753M -$2.682M $1.534M
YoY Change -538.25% -472.5% 203.16%
Net Earnings / Revenue -7.61% -12.07% 8.05%
Basic Earnings Per Share -$0.13 -$0.20 $0.12
Diluted Earnings Per Share -$0.13 -$0.20 $0.11
COMMON SHARES
Basic Shares Outstanding 13.20M 13.10M
Diluted Shares Outstanding 13.20M 13.47M

Balance Sheet

Concept 2018 Q3 2018 Q2 2018 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $64.70M $62.00M $66.00M
YoY Change 33.95% 41.88% 42.55%
Cash & Equivalents $23.32M $27.62M $28.06M
Short-Term Investments $41.40M $34.80M $38.30M
Other Short-Term Assets $2.900M $3.500M $2.700M
YoY Change 141.67% 40.0% 80.0%
Inventory $4.016M $4.000M $4.000M
Prepaid Expenses
Receivables $8.877M $8.300M $7.200M
Other Receivables $1.100M $1.100M $1.400M
Total Short-Term Assets $81.53M $78.80M $81.30M
YoY Change 33.91% 36.64% 39.21%
LONG-TERM ASSETS
Property, Plant & Equipment $30.14M $27.98M $25.80M
YoY Change 31.39% 25.73% 25.24%
Goodwill $27.03M
YoY Change -0.92%
Intangibles $17.68M
YoY Change -14.0%
Long-Term Investments $4.000M
YoY Change
Other Assets $1.446M $7.600M $4.500M
YoY Change 61.2% 766.59% -13.46%
Total Long-Term Assets $82.61M $81.20M $82.00M
YoY Change 9.11% 9.4% 12.48%
TOTAL ASSETS
Total Short-Term Assets $81.53M $78.80M $81.30M
Total Long-Term Assets $82.61M $81.20M $82.00M
Total Assets $164.1M $160.0M $163.3M
YoY Change 20.16% 21.31% 24.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.546M $1.700M $2.000M
YoY Change 6.26% -11.27% -4.76%
Accrued Expenses $11.90M $7.900M $7.900M
YoY Change 112.5% 79.55% 119.44%
Deferred Revenue $9.646M
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $35.13M $31.60M $34.20M
YoY Change 258.39% 321.33% 410.45%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $5.720M $19.70M $15.70M
YoY Change 195.15% 31.33% 3.97%
Total Long-Term Liabilities $5.720M $19.70M $15.70M
YoY Change 195.15% 31.33% 3.97%
TOTAL LIABILITIES
Total Short-Term Liabilities $35.13M $31.60M $34.20M
Total Long-Term Liabilities $5.720M $19.70M $15.70M
Total Liabilities $55.53M $51.20M $50.00M
YoY Change 121.78% 127.56% 128.31%
SHAREHOLDERS EQUITY
Retained Earnings $97.62M
YoY Change -4.37%
Common Stock $8.277M
YoY Change 36.4%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $108.6M $108.7M $113.4M
YoY Change
Total Liabilities & Shareholders Equity $164.1M $160.0M $163.3M
YoY Change 20.16% 21.3% 24.37%

Cashflow Statement

Concept 2018 Q3 2018 Q2 2018 Q1
OPERATING ACTIVITIES
Net Income -$1.753M -$2.682M $1.534M
YoY Change -538.25% -472.5% 203.16%
Depreciation, Depletion And Amortization $1.720M $1.605M $1.586M
YoY Change 10.97% 14.23% 19.43%
Cash From Operating Activities $4.830M $1.790M $26.82M
YoY Change -24.41% -47.35% 1061.04%
INVESTING ACTIVITIES
Capital Expenditures -$2.670M -$7.400M -$2.720M
YoY Change 72.26% 268.16% 106.06%
Acquisitions
YoY Change
Other Investing Activities -$6.590M $7.520M -$17.38M
YoY Change -1198.33% 187.02% 131.42%
Cash From Investing Activities -$9.270M $130.0K -$20.10M
YoY Change 886.17% -78.33% 127.63%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 500.0K -2.210M -700.0K
YoY Change -208.7% -44.89% -736.36%
NET CHANGE
Cash From Operating Activities 4.830M 1.790M 26.82M
Cash From Investing Activities -9.270M 130.0K -20.10M
Cash From Financing Activities 500.0K -2.210M -700.0K
Net Change In Cash -3.940M -290.0K 6.020M
YoY Change -178.96% 2800.0% -193.92%
FREE CASH FLOW
Cash From Operating Activities $4.830M $1.790M $26.82M
Capital Expenditures -$2.670M -$7.400M -$2.720M
Free Cash Flow $7.500M $9.190M $29.54M
YoY Change -5.54% 69.87% 713.77%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
350000
CY2018Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8877000
CY2019Q3 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
6176000
CY2017 us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
us-gaap:ProductMember
CY2018Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q3 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
41352000
CY2018Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
147000
CY2018 us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
us-gaap:ProductMember
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-8799000
CY2017 us-gaap Investment Income Net
InvestmentIncomeNet
390000
CY2019 us-gaap Costs And Expenses
CostsAndExpenses
93608000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
6469000
CY2018 us-gaap Investment Income Net
InvestmentIncomeNet
851000
CY2019 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
64000
CY2019 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
890000
CY2018 srdx Contingent Consideration Expense Gain
ContingentConsiderationExpenseGain
675000
CY2019 srdx Contingent Consideration Expense Gain
ContingentConsiderationExpenseGain
-161000
CY2019Q3 srdx Accrued Purchases Current
AccruedPurchasesCurrent
679000
CY2019Q3 srdx Accrued Clinical Study Expense Current
AccruedClinicalStudyExpenseCurrent
2163000
CY2017 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2114000
CY2016Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
24987000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
30361000
CY2018 srdx Non Cash Transaction Acquisition Of Property Plant And Equipment Net Of Refundable Credits In Other Current Assets And Liabilities
NonCashTransactionAcquisitionOfPropertyPlantAndEquipmentNetOfRefundableCreditsInOtherCurrentAssetsAndLiabilities
632000
CY2017 srdx Non Cash Transaction Acquisition Of Property Plant And Equipment Net Of Refundable Credits In Other Current Assets And Liabilities
NonCashTransactionAcquisitionOfPropertyPlantAndEquipmentNetOfRefundableCreditsInOtherCurrentAssetsAndLiabilities
109000
CY2018Q3 us-gaap Liabilities Current
LiabilitiesCurrent
35133000
CY2018Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.05
CY2018Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
450000
CY2018Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.05
CY2018Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
45000000
CY2018Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13397647
CY2018Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13397647
CY2018Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2718000
CY2018Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
97615000
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
108610000
CY2018Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
164135000
CY2018 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
24111000
CY2019 us-gaap Investment Income Net
InvestmentIncomeNet
1097000
CY2019 us-gaap Interest Expense
InterestExpense
152000
CY2017 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-504000
CY2018 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1267000
CY2017 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-70000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7532000
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7033000
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3075000
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3107000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-4457000
CY2017 us-gaap Net Income Loss
NetIncomeLoss
3926000
CY2017 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.30
CY2018Q3 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
6304000
CY2018Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
11041000
CY2018Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
3425000
CY2019Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
11628000
CY2018Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
11247000
CY2018Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5720000
CY2018Q3 us-gaap Liabilities
Liabilities
55525000
CY2018Q3 us-gaap Common Stock Value
CommonStockValue
670000
CY2018Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
7607000
CY2018 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
7888000
CY2018 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
239000
CY2019 srdx Gain Loss On Sale Of Strategic Investment And Other Nonoperating Income Expense
GainLossOnSaleOfStrategicInvestmentAndOtherNonoperatingIncomeExpense
10000
CY2018 srdx Gain Loss On Sale Of Strategic Investment And Other Nonoperating Income Expense
GainLossOnSaleOfStrategicInvestmentAndOtherNonoperatingIncomeExpense
177000
CY2017 srdx Gain Loss On Sale Of Strategic Investment And Other Nonoperating Income Expense
GainLossOnSaleOfStrategicInvestmentAndOtherNonoperatingIncomeExpense
44000
CY2016Q3 us-gaap Stockholders Equity
StockholdersEquity
106833000
CY2017 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
348000
CY2017 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
96000
CY2017 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
4702000
CY2017 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
560000
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3472000
CY2017Q3 us-gaap Stockholders Equity
StockholdersEquity
111557000
CY2018 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
340000
CY2017 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-59000
CY2018 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1749000
CY2019 us-gaap New Accounting Pronouncement Or Change In Accounting Principle Effect Of Adoption Quantification
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification
5498000
CY2019 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
441000
CY2019 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
2662000
CY2019 us-gaap Profit Loss
ProfitLoss
7592000
CY2018 us-gaap Profit Loss
ProfitLoss
-4457000
CY2017 us-gaap Profit Loss
ProfitLoss
3926000
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7312000
CY2018 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6431000
CY2017 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5555000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5077000
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4807000
CY2017 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3472000
CY2019 us-gaap Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
2041000
CY2019 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-161000
CY2018 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
675000
CY2017 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-127000
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1088000
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2277000
CY2017 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1000000
CY2019 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
7000
CY2018 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
177000
CY2017 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
43000
CY2019 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
160000
CY2018 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
85000
CY2017 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
208000
CY2019 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
259000
CY2017 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
427000
CY2019 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
10000
CY2017 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-6000
CY2018 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
148000
CY2017 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-474000
CY2019 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1000
CY2018 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-45000
CY2019 srdx Increase Decrease In Accounts Receivable And Contract With Customer Asset
IncreaseDecreaseInAccountsReceivableAndContractWithCustomerAsset
1630000
CY2018 srdx Increase Decrease In Accounts Receivable And Contract With Customer Asset
IncreaseDecreaseInAccountsReceivableAndContractWithCustomerAsset
1773000
CY2017 srdx Increase Decrease In Accounts Receivable And Contract With Customer Asset
IncreaseDecreaseInAccountsReceivableAndContractWithCustomerAsset
528000
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
543000
CY2018 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
513000
CY2017 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-97000
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2131000
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1584000
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
599000
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-765000
CY2018 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
155000
CY2017 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1101000
CY2019 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2187000
CY2018 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
5086000
CY2017 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-733000
CY2019 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-3512000
CY2018 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
20651000
CY2017 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-124000
CY2019 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
822000
CY2018 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-842000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
8038000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
34052000
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
14053000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5998000
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9092000
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6432000
CY2019 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
10000
CY2019 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
44973000
CY2018 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
81536000
CY2017 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
73671000
CY2019 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
61458000
CY2018 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
71951000
CY2017 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
63871000
CY2019 us-gaap Payments To Acquire In Process Research And Development
PaymentsToAcquireInProcessResearchAndDevelopment
750000
CY2018 us-gaap Payments To Acquire In Process Research And Development
PaymentsToAcquireInProcessResearchAndDevelopment
5000000
CY2019 us-gaap Proceeds From Sales Of Assets Investing Activities
ProceedsFromSalesOfAssetsInvestingActivities
7000
CY2018 us-gaap Proceeds From Sales Of Assets Investing Activities
ProceedsFromSalesOfAssetsInvestingActivities
177000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
9754000
CY2017 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
444000
CY2018 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
4557000
CY2017 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2156000
CY2019 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
9064000
CY2018 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
925000
CY2017 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
96000
CY2017 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
4702000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-11029000
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3393000
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-6510000
CY2019 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-70000
CY2018 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-25000
CY2017 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
193000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
6693000
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
7134000
CY2017 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8453000
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
23668000
CY2017Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
16534000
CY2019 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
193000
CY2018 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
914000
CY2019 srdx Non Cash Transaction Acquisition Of Property Plant And Equipment Net Of Refundable Credits In Other Current Assets And Liabilities
NonCashTransactionAcquisitionOfPropertyPlantAndEquipmentNetOfRefundableCreditsInOtherCurrentAssetsAndLiabilities
202000
CY2018 srdx Noncash Transaction Acquisition Of Property Plant And Equipment In Long Term Deferred Rent
NoncashTransactionAcquisitionOfPropertyPlantAndEquipmentInLongTermDeferredRent
1200000
CY2019 srdx Non Cash Transaction Acquisition Of In Process Research And Development In Other Long Term Liabilities
NonCashTransactionAcquisitionOfInProcessResearchAndDevelopmentInOtherLongTermLiabilities
140000
CY2018 srdx Non Cash Transaction Acquisition Of In Process Research And Development In Other Long Term Liabilities
NonCashTransactionAcquisitionOfInProcessResearchAndDevelopmentInOtherLongTermLiabilities
2888000
CY2019 srdx Noncash Transaction Accrual Of Employee Taxes On Common Stock Exercises
NoncashTransactionAccrualOfEmployeeTaxesOnCommonStockExercises
104000
CY2018 srdx Noncash Transaction Accrual Of Employee Taxes On Common Stock Exercises
NoncashTransactionAccrualOfEmployeeTaxesOnCommonStockExercises
130000
CY2019Q3 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
24918000
CY2019Q3 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
13000
CY2019 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-top:18pt;margin-bottom:0pt;margin-left:2.27%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Calibri;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Calibri;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Ultimate results could differ from those estimates.</p>
CY2019 us-gaap Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities
0
CY2019Q3 us-gaap Available For Sale Securities
AvailableForSaleSecurities
24931000
CY2018Q3 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
41403000
CY2018Q3 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
51000
CY2018Q3 us-gaap Available For Sale Securities
AvailableForSaleSecurities
41352000
CY2019Q3 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
0
CY2018Q3 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
0
CY2019 us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
0
CY2018 us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
0
CY2017 us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
0
CY2019Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
2034000
CY2018Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
1890000
CY2019Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
892000
CY2018Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
780000
CY2019Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1575000
CY2018Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1346000
CY2019 us-gaap Depreciation
Depreciation
4700000
CY2018 us-gaap Depreciation
Depreciation
3700000
CY2017 us-gaap Depreciation
Depreciation
3000000
CY2019Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
37989000
CY2018Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
33512000
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2600000
CY2019Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
29995000
CY2019Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
15769000
CY2018Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
31140000
CY2018Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
13457000
CY2019Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2414000
CY2019Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2275000
CY2019Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2235000
CY2019Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1629000
CY2019Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1584000
CY2018 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0
CY2017 srdx Impairment Losses Of Intangible Assets Indefinite Lived Excluding Goodwill Other
ImpairmentLossesOfIntangibleAssetsIndefiniteLivedExcludingGoodwillOther
0
CY2019 srdx Impairment Losses Of Intangible Assets Indefinite Lived Excluding Goodwill Other
ImpairmentLossesOfIntangibleAssetsIndefiniteLivedExcludingGoodwillOther
0
CY2019 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2018 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2017 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2019Q3 srdx Goodwill Subject To Revaluation Due To Fluctuations In Exchange Rates
GoodwillSubjectToRevaluationDueToFluctuationsInExchangeRates
13400000
CY2017Q3 us-gaap Goodwill
Goodwill
27282000
CY2018 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-250000
CY2019 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-861000
CY2019 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2018 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2017 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2019Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
434000
CY2018Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
311000
CY2018Q3 srdx Accrued Clinical Study Expense Current
AccruedClinicalStudyExpenseCurrent
2839000
CY2018Q3 srdx Accrued Purchases Current
AccruedPurchasesCurrent
533000
CY2019Q3 srdx Acquisition Of In Process Research And Development Current
AcquisitionOfInProcessResearchAndDevelopmentCurrent
989000
CY2019Q3 us-gaap Accrued Rent Current
AccruedRentCurrent
130000
CY2018Q3 us-gaap Accrued Rent Current
AccruedRentCurrent
121000
CY2019Q3 srdx Other Accrued Liabilities Other Current
OtherAccruedLiabilitiesOtherCurrent
395000
CY2018Q3 srdx Other Accrued Liabilities Other Current
OtherAccruedLiabilitiesOtherCurrent
262000
CY2018Q3 srdx Customer Claim Current
CustomerClaimCurrent
1000000
CY2018Q3 us-gaap Construction Payable Current
ConstructionPayableCurrent
1199000
CY2019 srdx Sales Based And Minimum Royalties Due Period
SalesBasedAndMinimumRoyaltiesDuePeriod
P45D
CY2019 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
7592000
CY2018 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-4457000
CY2017 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
3926000
CY2019 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
390000
CY2017 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
236000
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
200000
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1000000
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
200000
CY2018Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
9646000
CY2018Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
11247000
CY2019Q3 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
1200000
CY2019Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
0
CY2018Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
0
CY2017 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
196190
CY2017 srdx Stock Repurchased During Period Average Price
StockRepurchasedDuringPeriodAveragePrice
23.97
CY2019Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
25300000
CY2019Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
6900000
CY2019 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y2M12D
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
1355000
CY2018 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-890000
CY2017 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
2125000
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
192000
CY2018 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
51000
CY2017 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-72000
CY2019 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
41000
CY2018 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
41000
CY2017 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
54000
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1588000
CY2018 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-798000
CY2017 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
2107000
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-1505000
CY2018 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-2006000
CY2017 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
1085000
CY2019 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-117000
CY2018 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-271000
CY2017 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-85000
CY2019 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
-1622000
CY2018 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
-2277000
CY2017 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
1000000
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.245
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2017Q4 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2017Q4 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2018 srdx Tax Cuts And Jobs Act Change In Tax Rate Deferred Tax Asset Income Tax Expense
TaxCutsAndJobsActChangeInTaxRateDeferredTaxAssetIncomeTaxExpense
1600000
CY2019 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
1587000
CY2018 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1845000
CY2017 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
2461000
CY2019 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-452000
CY2018 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-724000
CY2017 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-13000
CY2019 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
2464000
CY2018 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
1710000
CY2017 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
706000
CY2019 srdx Income Tax Reconciliation Foreign And State Income Tax Rate Differential
IncomeTaxReconciliationForeignAndStateIncomeTaxRateDifferential
156000
CY2018 srdx Income Tax Reconciliation Foreign And State Income Tax Rate Differential
IncomeTaxReconciliationForeignAndStateIncomeTaxRateDifferential
371000
CY2017 srdx Income Tax Reconciliation Foreign And State Income Tax Rate Differential
IncomeTaxReconciliationForeignAndStateIncomeTaxRateDifferential
948000
CY2019 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
671000
CY2018 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
960000
CY2017 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
665000
CY2017 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
330000
CY2019 srdx Income Tax Reconciliation Contingent Consideration Gain Expense And Related Foreign Currency Revaluation
IncomeTaxReconciliationContingentConsiderationGainExpenseAndRelatedForeignCurrencyRevaluation
-61000
CY2018 srdx Income Tax Reconciliation Contingent Consideration Gain Expense And Related Foreign Currency Revaluation
IncomeTaxReconciliationContingentConsiderationGainExpenseAndRelatedForeignCurrencyRevaluation
142000
CY2017 srdx Income Tax Reconciliation Contingent Consideration Gain Expense And Related Foreign Currency Revaluation
IncomeTaxReconciliationContingentConsiderationGainExpenseAndRelatedForeignCurrencyRevaluation
125000
CY2019 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
44000
CY2018 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
1582000
CY2019 us-gaap Income Tax Reconciliation Tax Contingencies
IncomeTaxReconciliationTaxContingencies
770000
CY2019 us-gaap Income Tax Reconciliation Deductions Extraterritorial Income Exclusion
IncomeTaxReconciliationDeductionsExtraterritorialIncomeExclusion
150000
CY2019 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
28000
CY2018 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
54000
CY2017 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-338000
CY2019 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
500000
CY2018 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
2000000
CY2017 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
-200000
CY2019Q3 srdx Deferred Tax Assets Liabilities Property Plant And Equipment
DeferredTaxAssetsLiabilitiesPropertyPlantAndEquipment
-905000
CY2018Q3 srdx Deferred Tax Assets Liabilities Property Plant And Equipment
DeferredTaxAssetsLiabilitiesPropertyPlantAndEquipment
-1019000
CY2019Q3 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
1554000
CY2019Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
585000
CY2018Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
1308000
CY2019Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2213000
CY2018Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1798000
CY2019Q3 srdx Deferred Tax Assets Impaired Investment
DeferredTaxAssetsImpairedInvestment
1666000
CY2018Q3 srdx Deferred Tax Assets Impaired Investment
DeferredTaxAssetsImpairedInvestment
1687000
CY2019Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
3308000
CY2018Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
4637000
CY2019Q3 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
2394000
CY2018Q3 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
1896000
CY2019Q3 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
689000
CY2018Q3 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
538000
CY2019Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
5328000
CY2018Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
4541000
CY2019 srdx Operating Loss Carryforwards Remaining Period
OperatingLossCarryforwardsRemainingPeriod
P9Y
CY2018Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1559000
CY2017Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1481000
CY2016Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1508000
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
278000
CY2018 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
61000
CY2017 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
8000
CY2019 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
2000
CY2017 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
35000
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
735000
CY2018 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
735000
CY2017 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
216000
CY2018 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
613000
CY2019 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
247000
CY2018 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
105000
CY2017 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
216000
CY2019Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2323000
CY2019Q3 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
2100000
CY2018Q3 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
1400000
CY2017Q3 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
1200000
CY2019Q3 us-gaap Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit
SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit
500000
CY2018Q3 us-gaap Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit
SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit
400000
CY2017Q3 us-gaap Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit
SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit
500000
CY2019Q3 us-gaap Undistributed Earnings Of Foreign Subsidiaries
UndistributedEarningsOfForeignSubsidiaries
0
CY2018Q3 us-gaap Undistributed Earnings Of Foreign Subsidiaries
UndistributedEarningsOfForeignSubsidiaries
0
CY2019 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
900000
CY2018 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
700000
CY2017 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
700000
CY2019 us-gaap Loss Contingency Accrual Payments
LossContingencyAccrualPayments
400000
CY2019 srdx Additional Shares Of Common Stock To Stockholders
AdditionalSharesOfCommonStockToStockholders
480059
CY2019 srdx License Agreement Commencement Date
LicenseAgreementCommencementDate
2006-03
CY2019Q3 us-gaap Foreign Currency Exchange Rate Translation1
ForeignCurrencyExchangeRateTranslation1
1.0916
CY2019Q3 srdx Annual License Maintenance Fee Payable
AnnualLicenseMaintenanceFeePayable
1700000
CY2019 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
500000
CY2018 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
500000
CY2017 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
100000
CY2019Q3 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
493000
CY2019Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
538000
CY2019Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
536000
CY2019Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
547000
CY2019Q3 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
558000
CY2019Q3 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
2092000
CY2019Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
4765000
CY2019 srdx Number Of Sources Of Revenues
NumberOfSourcesOfRevenues
2
CY2018Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
22241000
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
22676000
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
24344000
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
30816000
CY2018Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
712000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
865000
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
1017000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
3875000
CY2018Q4 us-gaap Net Income Loss
NetIncomeLoss
1310000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
1262000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
1466000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
3554000
CY2018Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.10
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.11
CY2018Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.11
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.26
CY2017Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
17013000
CY2017Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-633000
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
525000
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-6250000
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2441000
CY2017Q4 us-gaap Net Income Loss
NetIncomeLoss
-1556000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
1534000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-2682000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-1753000
CY2017Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
CY2018Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
CY2018Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
CY2018Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2017Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
CY2018Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.11
CY2018Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.20
CY2018Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
CY2017Q4 srdx Tax Cuts And Jobs Act Change In Tax Rate Deferred Tax Asset Income Tax Expense
TaxCutsAndJobsActChangeInTaxRateDeferredTaxAssetIncomeTaxExpense
1200000

Files In Submission

Name View Source Status
0001564590-19-045173-index-headers.html Edgar Link pending
0001564590-19-045173-index.html Edgar Link pending
0001564590-19-045173.txt Edgar Link pending
0001564590-19-045173-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gjtyvxza4rug000001.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
srdx-10k_20190930.htm Edgar Link pending
srdx-20190930.xml Edgar Link completed
srdx-20190930.xsd Edgar Link pending
srdx-20190930_cal.xml Edgar Link unprocessable
srdx-20190930_def.xml Edgar Link unprocessable
srdx-20190930_lab.xml Edgar Link unprocessable
srdx-20190930_pre.xml Edgar Link unprocessable
srdx-ex21_7.htm Edgar Link pending
srdx-ex23_12.htm Edgar Link pending
srdx-ex311_6.htm Edgar Link pending
srdx-ex312_8.htm Edgar Link pending
srdx-ex321_11.htm Edgar Link pending
srdx-ex322_10.htm Edgar Link pending
srdx-ex41_39.htm Edgar Link pending